MetLife Investment Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$610,218
-13.0%
52,2000.0%0.01%0.0%
Q2 2023$701,568
-16.2%
52,200
+3.4%
0.01%
-16.7%
Q1 2023$837,025
-10.9%
50,4840.0%0.01%
-14.3%
Q4 2022$939,002
+37.8%
50,484
-4.9%
0.01%
+16.7%
Q3 2022$681,196
+83.0%
53,0940.0%0.01%
+100.0%
Q2 2022$372,189
-9.0%
53,094
+7.6%
0.00%0.0%
Q1 2022$409,087
+71.0%
49,347
+39.7%
0.00%
+50.0%
Q4 2021$239,184
+75.6%
35,330
+37.5%
0.00%
+100.0%
Q3 2021$136,199
-43.9%
25,698
-39.1%
0.00%
-50.0%
Q2 2021$242,765
+24.7%
42,2200.0%0.00%0.0%
Q1 2021$194,634
+247.5%
42,220
+151.8%
0.00%
+100.0%
Q4 2020$56,005
-4.8%
16,768
-15.3%
0.00%0.0%
Q3 2020$58,824
-72.2%
19,806
-56.8%
0.00%
-50.0%
Q2 2020$211,628
+20.0%
45,8070.0%0.00%0.0%
Q1 2020$176,357
+85.8%
45,807
+81.0%
0.00%
+100.0%
Q4 2019$94,920
-63.7%
25,312
-48.6%
0.00%
-66.7%
Q3 2019$261,480
+38.3%
49,2430.0%0.00%
+50.0%
Q2 2019$189,093
-24.7%
49,2430.0%0.00%
-33.3%
Q1 2019$251,139
+165.6%
49,2430.0%0.00%
+200.0%
Q4 2018$94,547
-49.2%
49,2430.0%0.00%
-50.0%
Q3 2018$186,139
+18.6%
49,243
-2.2%
0.00%0.0%
Q2 2018$157,000
+9.0%
50,349
+36.5%
0.00%0.0%
Q4 2017$144,00036,8770.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders